Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial-Reference-Cited by-同舟云学术

Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial

Published:2016-08 Issue: Volume:63 Page:97-104
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ignatiadis Michail,Rack Brigitte,Rothé Francoise,Riethdorf Sabine,Decraene Charles,Bonnefoi Hervé,Dittrich Christian,Messina Carlo,Beauvois Melanie,Trapp Elisabeth,Goulioti Theodora,Tryfonidis Konstantinos,Pantel Klaus,Repollet Madeline,Janni Wolfgang,Piccart Martine,Sotiriou Christos,Litiere Saskia,Pierga Jean-Yves

Funder

Hoffmann-La Roche and Janssen Diagnostics

EORTC Cancer Research Fund

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von;J Clin Oncol,2012

2. Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies;Berruti;J Clin Oncol,2014

3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

4. PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer;Loibl;J Clin Oncol,2014

5. PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer;Majewski;J Clin Oncol,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of liquid biopsy in lung cancer management;Indian Journal of Pathology and Microbiology;2024-07

2. Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells;International Journal of Molecular Sciences;2024-04-29

3. Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA);Breast Cancer Research and Treatment;2024-02-15

4. Breast cancer: polyclonality as a fact of resistance to antitumor treatment;Scientific Bulletin of the Omsk State Medical University;2023-09-18

5. State of the Art in the Propagation of Circulating Tumor Cells;Circulating Tumor Cells;2023